The most recent studies and meta-analyses proved that the lipid lowering therapy, the lowering of LDL-cholesterol level has become the key element of the primary and secondary cardiovascular prevention. There is no difference which drug is used, but LDL-cholesterol must be decreased to the lowest achievable level, as soon, as long and as low, as possible. Obviously, it is clear as well, that if the risk is higher, the available benefit is greater. At the same time we have to recognise that in lipid lowering treatment of patients after acute coronary syndrome there is still remaining room and urgent task for improvement. The presidents and general secretaries of two medical associations, the Hungarian Society of Cardiology and the Hungarian Atherosclerosis Society, and the leaders of cardiology departments of four counties in the North-Eastern part of Hungary (Borsod-Abaúj-Zemplén, Szabolcs-Szatmár-Bereg, Hajdú-Bihar and Békés) and a cardiologist working as a general practitioner too, developed a common action plan to improve the lipid lowering treatment in patients after ACS. Its key elements are: 1.) detailed instructions for patients about next steps on hospital discharge report; 2.) increased involvement of general practitioners; 3.) exact timing and raising awareness of follow-up examinations; 4.) accurate planning of laboratory controls; 5.) the better patient education. In order to improve long-term cardiovascular morbidity and mortality, it would be important for all colleagues who are is involved in the management of patients with acute coronary syndrome, such as discharging cardiologists, caregiver specialists and general practitioners to routinely apply recommendations listed in this article. In this practice trained nurses could be involved as well, in addition the optimalisation of lipid lowering treatment is a therapeutic area too, where the advantage of telemedicine should be applied.